Claus Bachert, MD, PhD, Cezmi A. Akdis, MD

Slides:

Advertisements

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Advertisements

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Staphylococcus aureus sensitization and allergic disease in early childhood: Population- based birth cohort study Aida Semic-Jusufagic, MD, Claus Bachert,

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS

What drives prescription patterns in pediatric asthma management?

Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD

Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo Eli O. Meltzer, MD, Claus Bachert,

Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations Peter G. Gibson, MBBS(Hons),

Fatty acids, inflammation, and asthma

Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Ann-Marie M. Schoos, MD, PhD, Jacob D

Jan Lötvall, MD, Cezmi A. Akdis, MD, Leonard B

Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma Christine L.M. Joseph,

Is 9 more than 2 also in allergic airway inflammation?

Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial Marko Kalliomäki, MD, PhD,

Desensitization to Chemotherapeutic Agents

Fatty acids, inflammation, and asthma

Allergic skin diseases

Rising prevalence of asthma is sex-specific in a US farming population

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies.

The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trials

Peter M. Wolfgram, MD, David B. Allen, MD

The future of allergy/immunology: Promising young investigators

An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1– related disease in children Kumud K. Singh, PhD, Alexis Lieser, MD,

Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA

Reply Journal of Allergy and Clinical Immunology

Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management Scott H. Sicherer, MD, Hugh A. Sampson, MD Journal.

Biosimilars and drug development in allergic and immunologic diseases

Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A

News Beyond Our Pages Journal of Allergy and Clinical Immunology

A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS

Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think Martin L. Moore, PhD, R.

What is an “eosinophilic phenotype” of asthma?

Cephalosporin Side Chain Cross-reactivity

Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD

Medication use in children with asthma in Finland from 1995 to 2006

The widening black/white gap in asthma hospitalizations and mortality

Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo Eli O. Meltzer, MD, Claus Bachert,

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

Autophagy: Nobel Prize 2016 and allergy and asthma research

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Advances in the approach to the patient with food allergy

Diagnosis and management of early asthma in preschool-aged children

A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children Felicia A. Rabito, PhD, MPH, John C. Carlson,

Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L

Corinne A. Keet, MD, MS, Wayne G. Shreffler, MD, PhD, Roger D

Prevention of food allergy: Beyond peanut

One step forward, 2 steps back: The enigma of preschool wheeze

Risk of oral food challenges

The mediating effect of microbial colonization on the effect of cesarean section delivery Adrian J. Lowe, PhD, Elizabeth Williamson, PhD, Lennart Bråbäck,

The role of indoor allergens in chronic allergic disease

Measles and immunomodulation

The Editors' Choice Journal of Allergy and Clinical Immunology

Macrolide antibiotics and asthma treatment

Neil W. Johnston, MSc, Sebastian L. Johnston, MD, PhD, Joanne M

Asthma: The past, future, environment, and costs

Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization.

Environmental factors and eosinophilic esophagitis

The GILL study: Glycerin-induced local reactions in immunotherapy

Advances in pediatric asthma in 2007

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Negative affect, medication adherence, and asthma control in children

Natural history of cow’s milk allergy

Susan L. Janson, DNSc, Kelly Wong McGrath, BA, Jack K

Primary prevention of asthma and allergy

Presentation transcript:

Specific allergy and asthma prevention coming to an age: A milestone in children Claus Bachert, MD, PhD, Cezmi A. Akdis, MD Journal of Allergy and Clinical Immunology Volume 141, Issue 2, Pages 527-528 (February 2018) DOI: 10.1016/j.jaci.2017.08.022 Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Improved features of asthma and allergic rhinoconjunctivitis in the GAP trial: asthma symptoms (odds ratio [OR], 0543; P = .017); asthma medication use (OR, 0.337; P = .002); asthma symptoms and asthma medication use (OR, 0.278; P = .0004); asthma symptoms, asthma medication use, and FEV1 reversibility of 12% or greater (OR, 0.177; P = .013); asthma symptoms, inhaled corticosteroid (ICS) use, and FEV1 reversibility of 12% or greater (OR, 0.205; P = .028). Journal of Allergy and Clinical Immunology 2018 141, 527-528DOI: (10.1016/j.jaci.2017.08.022) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions